Causes of the delay in creating permanent vascular access in hemodialysis patients

Maha A Alfarhan1, Shahad A Almatrafi1, Sumaia M Alqaseer2

  • 1College of Medicine, King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.

Insights

Physicians identified patient denial, fears, and refusal as primary reasons for delayed arteriovenous fistula (AVF) creation in chronic kidney disease (CKD) patients. Improving predialysis education and timely referrals are crucial for better patient outcomes.

Area of Science:

  • Nephrology
  • Vascular Access Surgery
  • Public Health

Background:

  • Chronic kidney disease (CKD) management often involves hemodialysis (HD), frequently accessed via central venous catheters (CVCs).
  • CVCs are associated with significant complications, highlighting the need for timely arteriovenous fistula (AVF) creation as preferred vascular access.
  • Understanding physician perspectives on delayed AVF creation is essential for improving CKD patient care in Saudi Arabia.

Purpose of the Study:

  • To investigate nephrologists' perspectives on the factors contributing to delayed AVF creation in the Kingdom of Saudi Arabia (KSA).
  • To identify patient, physician, and hospital-related reasons for the delay in establishing permanent vascular access for hemodialysis.
  • To inform strategies for optimizing AVF creation timing and preventing associated complications.

Main Methods:

  • A cross-sectional descriptive study was conducted among nephrologists in KSA.
  • A questionnaire was utilized to gather data on perceived reasons for AVF creation delays.
  • Factors were categorized into patient, physician, and hospital domains, with assessment of optimal dialysis initiation timing.

Main Results:

  • Patient-related factors, including denial of disease (76.4%), dialysis fears (75.9%), and refusal (73.1%), were cited as major contributors to delayed AVF creation.
  • Insufficient predialysis education (63.7%) and late nephrology referral (56.6%) were identified as key physician and hospital factors.
  • Most participants recommended AVF creation at Stage 4 (69.3%) or Stage 5 (27.4%) CKD, ideally 3-6 months before anticipated HD initiation.

Conclusions:

  • Patient-related issues are perceived as the predominant cause for delayed permanent vascular access, accounting for over two-thirds of delays.
  • There is a need for a standardized approach encompassing patient selection, patient-centered predialysis care, and timely referral for vascular access procedures.
  • Addressing these factors can enhance the quality of care and prognosis for CKD patients requiring hemodialysis.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
682
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
302
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
428
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
220
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
870
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
353